SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Myriad Genetics, Inc. (MYGN)
MYGN 6.565-3.2%Dec 23 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sim1 who wrote (2331)1/28/2011 8:50:37 PM
From: tom pope   of 2355
 
That's quite interesting, Stuart, it puts a possibly different perspective on the Sanofi bomb.

I had some MYGN that I sold yesterday evening - that was a good thing, but it wasn't because of any particular perspicacity. I'd held NVS thru its lackluster earnings and gloomy forecasts, and was determined not to make the same mistake two days in a row. Actually I was lucky with NVS - lost less than I expected after the earnings news appeared on the wire. MYGN would have been a disaster. Thank you NVS for triggering my caution.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News